State Board of Administration of Florida Retirement System’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-587
Closed -$86K 2336
2022
Q1
$86K Hold
587
﹤0.01% 2281
2021
Q4
$199K Buy
587
+9
+2% +$3.48K ﹤0.01% 2213
2021
Q3
$253K Hold
578
﹤0.01% 2164
2021
Q2
$202K Buy
578
+92
+19% +$35.7K ﹤0.01% 2281
2021
Q1
$178K Hold
486
﹤0.01% 2240
2020
Q4
$182K Hold
486
﹤0.01% 2193
2020
Q3
$219K Buy
486
+5
+1% +$2.88K ﹤0.01% 2024
2020
Q2
$354K Buy
+481
New +$348K ﹤0.01% 1803

Other funds holding CUE

State Board of Administration of Florida Retirement System's CUE Position: Q2 2022 in Review

State Board of Administration of Florida Retirement System sold out of Cue Biopharma (CUE) in Q2 2022, closing a stake of 587 shares — an estimated $86K sold.

State Board of Administration of Florida Retirement System first reported a position in CUE in Q2 2020 and held it in 8 quarters. The position peaked at $354K in Q2 2020. 75 funds tracked by Wall St. Rank hold CUE as of Q2 2022.

  • State Board of Administration of Florida Retirement System reported no remaining Cue Biopharma position as of Q2 2022 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 587 Cue Biopharma shares in Q2 2022, an estimated $86K.
  • State Board of Administration of Florida Retirement System first reported a position in Cue Biopharma in Q2 2020 and held it in 8 quarters.
  • State Board of Administration of Florida Retirement System's Cue Biopharma position peaked at $354K in Q2 2020.
  • 75 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2022.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2022, filed 5 Aug 2022.